Last reviewed · How we verify
Nitric Oxide Releasing Solution — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Nitric Oxide Releasing Solution (Nitric Oxide Releasing Solution) — Sanotize Research and Development corp..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Nitric Oxide Releasing Solution TARGET | Nitric Oxide Releasing Solution | Sanotize Research and Development corp. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Nitric Oxide Releasing Solution CI watch — RSS
- Nitric Oxide Releasing Solution CI watch — Atom
- Nitric Oxide Releasing Solution CI watch — JSON
- Nitric Oxide Releasing Solution alone — RSS
Cite this brief
Drug Landscape (2026). Nitric Oxide Releasing Solution — Competitive Intelligence Brief. https://druglandscape.com/ci/nitric-oxide-releasing-solution. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing